Cargando…
Effect of Denosumab on Bone Density in Postmenopausal Osteoporosis: A Comparison with and without Calcium Supplementation in Patients on Standard Diets in Korea
The side effects and safety issues tied to calcium supplementation raise questions about its necessity in osteoporosis treatment. We retrospectively evaluated 189 postmenopausal osteoporosis patients treated with denosumab for 12 months. Patients exhibited neither renal dysfunction nor compromised g...
Autores principales: | Jeong, Chaiho, Kim, Jinyoung, Lee, Jeongmin, Lim, Yejee, Lim, Dong-Jun, Baek, Ki-Hyun, Ha, Jeonghoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649665/ https://www.ncbi.nlm.nih.gov/pubmed/37959369 http://dx.doi.org/10.3390/jcm12216904 |
Ejemplares similares
-
The efficacy of denosumab in Korean male patients with osteoporosis
por: Jeong, Chaiho, et al.
Publicado: (2022) -
Effect of Romosozumab on Trabecular Bone Score Compared to Anti-Resorptive Agents in Postmenopausal Women with Osteoporosis
por: Jeong, Chaiho, et al.
Publicado: (2021) -
Effect of Romosozumab on Trabecular Bone Score Compared to Anti-Resorptive Agents in Postmenopausal Women with Osteoporosis
por: Jeong, Chaiho, et al.
Publicado: (2022) -
Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study
por: Jeong, Chaiho, et al.
Publicado: (2023) -
Roles of Follicle-Stimulating Hormone on Bone Metabolism in Late Postmenopausal Women
por: Jeong, Chaiho, et al.
Publicado: (2022)